Literature DB >> 20413002

The structure, role, and procedures of the U.S. Advisory Committee on Immunization Practices (ACIP).

Jean Clare Smith1.   

Abstract

The National Immunization Technical Advisory Group (NITAG) in the United States is the Advisory Committee on Immunization Practices (ACIP). The ACIP was established in 1964 by the US Surgeon General to assist in the prevention and control of communicable diseases, and includes a chair, an executive secretary, 15 voting members, 8 ex officio members and liaison representatives from 26 health-related professional organizations. Meetings are regularly convened at the Centers for Disease Control and Prevention (CDC) and are open to the public. Stringent measures and rigorous screening are used to avoid both real and apparent conflicts of interest, and no special interest or lobbying groups provide any material support to ACIP or its members. The committee recommends licensed new vaccines to be incorporated into the routine immunization schedule, recommends vaccine formulations, and reviews older vaccines to consider revising its recommendations. Published by Elsevier Ltd.

Mesh:

Substances:

Year:  2010        PMID: 20413002     DOI: 10.1016/j.vaccine.2010.02.037

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  24 in total

Review 1.  Overcoming perceptions of financial barriers to rotavirus vaccine introduction in Asia.

Authors:  E Anthony S Nelson; Ciro A de Quadros; Mathuram Santosham; Umesh D Parashar; Duncan Steele
Journal:  Hum Vaccin Immunother       Date:  2013-08-16       Impact factor: 3.452

2.  Timely Antiviral Administration During an Influenza Pandemic: Key Components.

Authors:  Lisa M Koonin; Anita Patel
Journal:  Am J Public Health       Date:  2018-09       Impact factor: 9.308

Review 3.  A review of the cost-effectiveness of adult influenza vaccination and other preventive services.

Authors:  Nazila M Dabestani; Andrew J Leidner; Eric E Seiber; Hyoshin Kim; Samuel B Graitcer; Ivo M Foppa; Carolyn B Bridges
Journal:  Prev Med       Date:  2019-05-29       Impact factor: 4.018

4.  Enhancing the work of the Department of Health and Human Services national vaccine program in global immunization: recommendations of the National Vaccine Advisory Committee: approved by the National Vaccine Advisory Committee on September 12, 2013.

Authors: 
Journal:  Public Health Rep       Date:  2014       Impact factor: 2.792

5.  Review of the economic evidence presented to the United States Advisory Committee on Immunization Practices, 2012-2016.

Authors:  Jamison Pike; Andrew J Leidner; Jessica R MacNeil; Amanda C Cohn
Journal:  Vaccine       Date:  2018-11-23       Impact factor: 3.641

Review 6.  The MMR Vaccine and Autism.

Authors:  Frank DeStefano; Tom T Shimabukuro
Journal:  Annu Rev Virol       Date:  2019-04-15       Impact factor: 10.431

Review 7.  Safety monitoring in the Vaccine Adverse Event Reporting System (VAERS).

Authors:  Tom T Shimabukuro; Michael Nguyen; David Martin; Frank DeStefano
Journal:  Vaccine       Date:  2015-07-22       Impact factor: 3.641

8.  Evaluating Harms in the Assessment of Net Benefit: A Framework for Newborn Screening Condition Review.

Authors:  Aaron J Goldenberg; Anne Marie Comeau; Scott D Grosse; Susan Tanksley; Lisa A Prosser; Jelili Ojodu; Jeffrey R Botkin; Alex R Kemper; Nancy S Green
Journal:  Matern Child Health J       Date:  2016-03

Review 9.  Enhancing vaccine safety capacity globally: A lifecycle perspective.

Authors:  Robert T Chen; Tom T Shimabukuro; David B Martin; Patrick L F Zuber; Daniel M Weibel; Miriam Sturkenboom
Journal:  Vaccine       Date:  2015-10-01       Impact factor: 3.641

10.  Moroccan National Immunization Technical Advisory Group: a valuable asset for the national immunization program and the immunization agenda in the EMRO region.

Authors:  Imane Jroundi; Mohammed Benazzouz; Abdel Hakim Yahyane; Moulay Tahar Alaoui; Nathalie El Omeiri
Journal:  Hum Vaccin Immunother       Date:  2021-05-14       Impact factor: 3.452

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.